We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia EIA
Product News

Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia EIA

Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia EIA
Product News

Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia EIA


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia EIA"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Pro-Lab Diagnostics has developed a new enzyme immunoassay (EIA) for the qualitative detection of Cryptosporidium and Giardia lamblia antigens in human faecal specimens from patients displaying gastrointestinal symptoms.

The Prolisa™ Cryptosporidium/Giardia EIA kit offers precise results with high sensitivity and excellent specificity, enabling accurate diagnosis of infection.

Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes or by immunostaining by direct fluorescent antibody, and can be difficult to detect.

Similarly, Giardia infection is frequently misdiagnosed, relying on poorly performing antigen-based testing.

Pro-Lab Diagnostics’ Prolisa™ Cryptosporidium/Giardia EIA is a convenient, rapid and easy-to-use method of detecting Cryptosporidium and G. lamblia.

Supplied in a 96-well test size consisting of detachable stripwells, this manual assay uses monoclonal anti-Cryptosporidium and anti- G. lamblia antibodies to ensure excellent sensitivity and specificity for high value diagnostic results, and can also be performed on most automated platforms for increased workflow flexibility.

Mark Reed, General Manager of Pro-Lab Diagnostics, commented: “The launch of the Cryptosporidium/Giardia EIA further extends the Prolisa product range, offering our customers a simple and cost-effective alternative means of testing for Cryptosporidiosis and Giardiasis with the back-up support of our team of application experts.”

Advertisement